CIP
AVNS icon

Champlain Investment Partners’s Avanos Medical AVNS Stock Holding History

Champlain Investment Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,174,483
Closed -$40.7M – 142
2021
Q4 		$40.7M Sell
1,174,483
-908,420
-44% -$29.4M 0.18% 125
2021
Q3 		$65M Sell
2,082,903
-524,130
-20% -$17.8M 0.31% 115
2021
Q2 		$94.8M Sell
2,607,033
-305,155
-10% -$12.6M 0.45% 96
2021
Q1 		$127M Sell
2,912,188
-558,747
-16% -$26.2M 0.66% 70
2020
Q4 		$159M Buy
3,470,935
+90,195
+3% +$3.75M 0.91% 45
2020
Q3 		$112M Buy
3,380,740
+27,085
+0.8% +$866K 0.76% 55
2020
Q2 		$98.6M Sell
3,353,655
-80,715
-2% -$2.34M 0.71% 56
2020
Q1 		$92.5M Buy
3,434,370
+100,073
+3% +$2.99M 0.83% 46
2019
Q4 		$112M Buy
3,334,297
+752,315
+29% +$27.2M 0.82% 52
2019
Q3 		$96.7M Buy
2,581,982
+126,450
+5% +$4.82M 0.8% 55
2019
Q2 		$107M Buy
2,455,532
+53,545
+2% +$2.29M 0.9% 51
2019
Q1 		$103M Buy
2,401,987
+304,015
+14% +$13.6M 0.89% 51
2018
Q4 		$94M Buy
2,097,972
+531,976
+34% +$27.9M 0.96% 47
2018
Q3 		$107M Buy
1,565,996
+525,206
+50% +$33.8M 0.95% 44
2018
Q2 		$59.6M Buy
1,040,790
+289,155
+38% +$15.3M 0.58% 79
2018
Q1 		$34.6M Buy
+751,635
New +$35.7M 0.37% 100
2016
Q3 		– Sell
-92,685
Closed -$3.01M – 142
2016
Q2 		$3.01M Sell
92,685
-383,850
-81% -$11.8M 0.05% 118
2016
Q1 		$13.7M Sell
476,535
-167,940
-26% -$4.47M 0.25% 114
2015
Q4 		$21.5M Sell
644,475
-399,626
-38% -$12.4M 0.37% 104
2015
Q3 		$29.7M Buy
1,044,101
+140,271
+16% +$4.89M 0.52% 86
2015
Q2 		$36.6M Buy
+903,830
New +$40.6M 0.58% 80

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Champlain Investment Partners's AVNS Position: Q1 2022 in Review

Champlain Investment Partners sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 1,174,483 shares — an estimated $40.7M sold.

Champlain Investment Partners first reported a position in AVNS in Q2 2015 and held it in 21 quarters. The position peaked at $159M in Q4 2020. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

  • Champlain Investment Partners reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
  • Champlain Investment Partners sold 1,174,483 Avanos Medical shares in Q1 2022, an estimated $40.7M.
  • Champlain Investment Partners first reported a position in Avanos Medical in Q2 2015 and held it in 21 quarters.
  • Champlain Investment Partners's Avanos Medical position peaked at $159M in Q4 2020.
  • 299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Champlain Investment Partners's 13F filing for Q1 2022, filed 12 May 2022.